Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

363 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A core outcome domain set to assess cutaneous neurofibromas related to neurofibromatosis type 1 in clinical trials.
Fertitta L, Bergqvist C, Sarin KY, Plotkin SR, Moertel C, Petersen AK, Cannon A, Berman Y, Pichard DC, Röhl C, Lessing A, Brizion B, Peiffer B, Ravaud P, Tran VT, Armand ML, Moryousef S, Ferkal S, Jannic A, Ezzedine K, Wolkenstein P; Response Evaluation in Neurofibromatosis and Schwannomatosis (REiNS) international collaboration. Fertitta L, et al. Among authors: ezzedine k. Br J Dermatol. 2024 Jan 23;190(2):216-225. doi: 10.1093/bjd/ljad397. Br J Dermatol. 2024. PMID: 37877514
cNF-Skindex in Adults Living with Neurofibromatosis 1: Severity Strata in France and Validation in United States Adults.
Fertitta L, Sarin KY, Bergqvist C, Patel E, Peiffer B, Moryousef S, Armand ML, Jannic A, Ferkal S, Ravaud P, Tran VT, Blakeley JO, Romo CG, Ezzedine K, Wolkenstein P. Fertitta L, et al. Among authors: ezzedine k. J Invest Dermatol. 2023 Nov;143(11):2226-2232.e1. doi: 10.1016/j.jid.2023.04.014. Epub 2023 May 5. J Invest Dermatol. 2023. PMID: 37149083 Free article.
Whole-Body Positron Emission Tomography with 18F-Fluorodeoxyglucose/Magnetic Resonance Imaging as a Screening Tool for the Detection of Malignant Transformation in Individuals with Neurofibromatosis Type 1.
Fertitta L, Jannic A, Zehou O, Bergqvist C, Ferkal S, Moryousef S, Lerman L, Mulé S, Luciani A, Bapst B, Ezzedine K, Ortonne N, Itti E, Wolkenstein P. Fertitta L, et al. Among authors: ezzedine k. J Invest Dermatol. 2024 Aug;144(8):1754-1761.e1. doi: 10.1016/j.jid.2024.01.028. Epub 2024 Feb 17. J Invest Dermatol. 2024. PMID: 38368929
Impact of Atopic Dermatitis on Patients and their Partners.
Misery L, Seneschal J, Corgibet F, Halioua B, Marquié A, Merhand S, Le Fur G, Staumont-Salle D, Bergqvist C, Taieb C, Ezzedine K, Richard MA. Misery L, et al. Among authors: ezzedine k. Acta Derm Venereol. 2023 Jun 26;103:adv5285. doi: 10.2340/actadv.v103.5285. Acta Derm Venereol. 2023. PMID: 37358393 Free PMC article.
Reliability and agreement testing of a new automated measurement method to determine facial vitiligo extent using standardized ultraviolet images and a dedicated algorithm.
Marin Dit Bertoud Q, Bertold C, Ezzedine K, Pandya AG, Cherel M, Castillo Martinez A, Seguy MA, Abdallah M, Bae JM, Böhm M, Parsad D, Rosmarin D, Wolkerstorfer A, Bahadoran P, Blaise M, Dugourd PM, Philippo V, Delaval JM, Passeron T. Marin Dit Bertoud Q, et al. Among authors: ezzedine k. Br J Dermatol. 2023 Dec 20;190(1):62-69. doi: 10.1093/bjd/ljad304. Br J Dermatol. 2023. PMID: 37615581
363 results